ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2414

Elevated Serum Resistin Levels In Rheumatoid Arthritis With Periodontitis

Byoong Yong Choi1, Jin-Hee Kim2, Kyung Hwa Kim2, Kyong Rok Kim3, Sang Hyun Joo4, Myeong Jae Yoon3, Hye Jin Oh5, Hye Won Kim3, Sung Hae Chang6, Eun Young Lee3, Eun Bong Lee7, Yong-Moo Lee2 and Yeong Wook Song3, 1Division of Rheumatology, Department of Internal Medicine, Seoul Medical Center, Seoul, South Korea, Seoul, South Korea, 2Department of Periodontology, School of Dentistry, Seoul National University, Seoul, South Korea, 3Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea, 4Division of Rheumatology, Department of Internal Medicine, Seoul National University, Seoul, South Korea, 5Seoul National University, Seoul, South Korea, 6Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea, 7Division of Rheumatology, Department of Internal Medicine,, Seoul National University College of Medicine, Seoul, South Korea

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: adipokines and rheumatoid arthritis, pathogenesis, Periodontitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis: Human Etiology and Pathogenesis II

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Epidemiological relationships between rheumatoid arthritis (RA) and periodontitis (PD) have been revealed recently. However, the pathologic link between RA and periodontitis has remained unclear. Resistin is adipokine which has been involved in insulin resistance in rodents but its pro-inflammatory properties are known to be superior to insulin resistance-inducing effects in human. Previous studies suggested that resistin may play a role in RA and periodontitis.

Methods:

Serum resistin levels were determined by enzyme-linked immunosorbent assay (ELISA). Ninety RA patients and 45 healthy subjects (2:1 age and gender matched). Serum samples were analysed for C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), anti-cyclic citrullinated peptide (anti-CCP), IgM rheumatoid factor. The disease activity was determined using the Disease Activity Score in 28 joints (DAS28). We divided the subjects into high (DAS28 ≥ 3.2) and low (DAS28 < 3.2) disease activity groups. Clinical measurement for PD such as plaque index (PI), gingival index (GI), probing pocket depth (PPD) and clinical attachment levels (CAL) were performed in total subjects.

Results:

Serum resistin levels were significantly increased in active RA patients (DAS28 ≥ 3.2; n = 49, median 11.5 ng/mL) compared to inactive RA patients (DAS28 < 3.2; n = 41, 7.3 ng/mL) or healthy control group (p < 0.01 and p < 0.05 respectively). In total RA patients, serum resistin levels were positively correlated with ESR (r = 0.25, p < 0.05), CRP (r = 0.48, p < 0.01) and DAS28 (r = 0.26, p < 0.05) as well as the severity of PD such as PI (r = 0.36, p < 0.001) and CAL (r = 0.29, p < 0.01). Active RA subgroup had more patients with clinically significant PD (n = 40/49, 81.6%) than inactive RA subgroup (n = 22/41, 53.7%; p < 0.01) and healthy controls (n = 14/45, 31.1%; p < 0.001). Serum resistin levels were also elevated in RA patients with anti-CCP antibody compared to those without (11.28 vs. 8.00 ng/mL, p < 0.05).

Conclusion:

Serum resistin levels were elevated in active RA patients compared to inactive RA patients or healthy controls, and associated with the severity of PD and the presence of anti-CCP. The present study suggests that resistin may play a role of pathologic cross-link between RA and PD.


Disclosure:

B. Y. Choi,
None;

J. H. Kim,
None;

K. H. Kim,
None;

K. R. Kim,
None;

S. H. Joo,
None;

M. J. Yoon,
None;

H. J. Oh,
None;

H. W. Kim,
None;

S. H. Chang,
None;

E. Y. Lee,
None;

E. B. Lee,
None;

Y. M. Lee,
None;

Y. W. Song,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/elevated-serum-resistin-levels-in-rheumatoid-arthritis-with-periodontitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology